|
Match
|
Document |
Document Title |
|
|
7678367 |
Method for reducing odor using metal-modified particles
A method for reducing odor is provided. In one embodiment, the method comprises forming a coordination complex between particles having a positive zeta potential and a transition metal. The method...
|
|
|
7678364 |
Particles for inhalation having sustained release properties
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to...
|
|
|
7674480 |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
The present invention provides a pharmaceutical composition for use in a dosage form for oral administration to a patient. The composition expands upon contact with gastric fluid and promotes...
|
|
|
7670627 |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
The present invention relates to a novel pH triggered, targeted controlled release system. The controlled delivery system of the present invention is substantially a free-flowing powder formed of...
|
|
|
7670623 |
Hemostatic composition
A hemostatic composition includes a carrier medium including a predetermined amount of a particulate material. The particulate material is comprised of core particles with a coating. The core...
|
|
|
7670592 |
Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same
The present invention relates to microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization...
|
|
|
7670625 |
Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent
The invention relates to a stable pharmaceutical composition useful in the treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD) and a novel...
|
|
|
7670626 |
Delivery of a bioactive material
A solid pharmaceutical composition comprising a water-soluble bioactive material and an encapsulating material which is present in the composition in the form of continuous solid phase, and in...
|
|
|
7670624 |
Gastrointestinal-specific multiple drug release system
The present invention provides compositions and methods for the multiple release of a drug in the gastrointestinal tract of a subject through the use of an oral multiple drug release system. The...
|
|
|
7666446 |
Oral formulation for delivery of poorly absorbed drugs
A composition for oral delivery of a poorly absorbed drug is disclosed. The composition includes the drug, an enhancer for increasing absorption of the drug through the intestinal mucosa, a...
|
|
|
7662403 |
Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
There is provided a powder formulation for nasal delivery including a protein having a molecular weight of 10 kDa or greater and chitosan or a derivative thereof or a salt of chitosan or a salt of...
|
|
|
7658948 |
Foaming granule and method for making same
A foaming granule is provided that includes an acid, a gas-evolving acid neutralizing agent, a surfactant foaming agent, and an active agent that is a plant growth enhancer, pest control agent,...
|
|
|
7658949 |
Surface modification of lactose excipient for use in powders for inhalation
The invention relates to a process for the surface-energy passivation of lactose which is intended for use as an excipient in the production of inhalable powders, and the use of such optimised...
|
|
|
7658998 |
Method of preparing sustained release microparticles
The present invention relates to a method for preparing an injectable composition of microparticles for the sustained release of a biologically active agent. The microparticles include a...
|
|
|
7658939 |
Tamper-resistant oral opioid agonist formulations
Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is...
|
|
|
7655250 |
Topical formulations comprising ceramic hydroxyapatite particles
Methods of using absorption enhancer as a component of skin care compositions for moisturizing and protecting the skin. Antimicrobial skin care compositions for cleansing and moisturizing the skin,...
|
|
|
7655259 |
Delayed release carnitine
A sustained release, orally administered pharmaceutical composition comprising carnitine and an acceptable pharmaceutical excipient is described for the treatment of carnitine deficiency and other...
|
|
|
7651699 |
Autoinducer compounds and their uses
The present invention discloses the autoinducer compounds, such as acyl homoserine lactones, acyl homocysteine lactone, acyl thiolactones, furanones or signal peptides, and their use in animal feed...
|
|
|
7651703 |
Injection vehicle for polymer-based formulations
The invention provides injection vehicles suitable for administering particulate suspensions, such as polymer-based formulations, as well as associated pharmaceutical formulations, articles of...
|
|
|
7648960 |
Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles
Methods are provided for purifying peptides and proteins by incorporating the peptide or protein into a diketopiperazine or competitive complexing agent to facilitate removal of one or more...
|
|
|
7645805 |
Gelling agents
The invention relates to a novel class of gelling agents, to a process of preparing said agents, to the use of said agents to prepare gels, and to the gels thus obtained. A gelling agent or...
|
|
|
7645442 |
Rapid-heating drug delivery article and method of use
A device, method, and system for producing a condensation aerosol are disclosed. The device includes a chamber having an upstream opening and a downstream opening which allow gas to flow through...
|
|
|
7641917 |
Method of encapsulating an active substance
The invention provides a method of encapsulating an active substance in an interpolymer complex, to make an encapsulated product in particulate form. The method comprises forming a mixture of a...
|
|
|
7638138 |
Compositions for nasal administration of pharmaceuticals
Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a...
|
|
|
7638506 |
Granular agrochemical composition
Provided is a granular agrochemical composition by which the problems accompanying the prior art granular agrochemical compositions can be overcome, which can be prepared in a simple formulation...
|
|
|
7635692 |
Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
A composition, useful in the prevention of osteoporosis, wherein said composition comprises (a) least one isoflavone and/or isoflavone glycoside, preferably genistein and/or genistin; (b) at least...
|
|
|
7632521 |
Controlled release potassium chloride tablets
A unit dosage form, such as a tablet for delivering potassium into the body in a controlled release fashion, comprises of a multiplicity of microencapsulated potassium chloride crystals, which are...
|
|
|
7628977 |
Particles for inhalation having sustained release properties
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to...
|
|
|
7628978 |
Stabilized preparations for use in metered dose inhalers
Stabilized dispersions are provided for the delivery of a bioactive agent to the respiratory tract of a patient. The dispersions preferably comprise a plurality of perforated microstructures...
|
|
|
7625574 |
Skin treatment composition
A skin treatment composition of the present invention is an external composition for skin comprising an alkylene oxide derivative expressed by Formula (I):
|
|
|
7625548 |
Methods and apparatus for producing nanoscale particles
Liquid nanoscale particle precursor materials for generating nanoscale particles include at least one high volatility carrier and a second component. A nanoscale particle generating device...
|
|
|
7618784 |
Assay for phospholipid transfer protein (PLTP) activity
Improved methods for assaying the activity of phospholipid transfer protein (PLTP) enhance the signal-to-noise ratio by providing the substrate in donor particles with an aqueous core in the...
|
|
|
7615547 |
Granulates containing liposoluble substances and a process for the preparation thereof
A process is described for the preparation of granulates that contain liposoluble and hydrophobic substances, preferably steroidal substances, and that exhibit rapid and excellent...
|
|
|
7612176 |
Polymer-based sustained release device
This invention relates to compositions for the sustained release of biologically active polypeptides, and methods of forming and using said compositions, for the sustained release of biologically...
|
|
|
7611709 |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
Disclosed are applications of oligosaccharides/oligosaccharide mixtures for the production and stabilization of pharmaceutical compositions, chiefly powders, that contain antibodies or antibody...
|
|
|
7611731 |
Mesostructured silica/block copolymer monoliths as a controlled release device and methods of manufacture
The invention comprises the design, synthesis, and characterization of mesostructured silica/block copolymer composite monoliths as controlled release systems. The controlled release function is...
|
|
|
7604819 |
Clay-based hemostatic agents and devices for the delivery thereof
A hemostatic device for promoting the clotting of blood includes a gauze substrate, a clay material disposed on the gauze substrate, and also a polyol such as glycerol or the like disposed on the...
|
|
|
7601337 |
Delivery of antipsychotics through an inhalation route
The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a...
|
|
|
7601363 |
Sustained-release drug formulations
The present invention relates to a formulation for implantation having a novel constitution, which accomplishes controlled releases of active ingredients. The formulation comprises one of...
|
|
|
7597897 |
Medicinal compositions and method for the preparation thereof
Methods for the manufacture of medicinal compositions are described. A method for the manufacture of a medicinal composition according to the invention comprises: (a) Providing a biocompatible...
|
|
|
7595348 |
Butyl lactate emulsions for the precipitation of water-insoluble drug nanoparticles
Emulsions for use in precipitating water-insoluble drug nanoparticles. The continuous phase of the emulsions include water and an external surfactant. The discontinuous phase of the emulsions...
|
|
|
7591999 |
Powdery preparation for nasal administration
According to the present invention, a powdery preparation for nasal administration comprising a physiologically active substance, a non-water-absorbing and hardly water-soluble powder(s) and one or...
|
|
|
7591993 |
Polyvinyl alcohol microspheres, and injectable solutions of the same
The present invention relates to microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization...
|
|
|
7588782 |
Rare earth metal compositions for treating hyperphosphatemia and related methods
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the...
|
|
|
7588780 |
Embolization
Embolic polymer particles are described. For example, the particles include pores such that the predominant size of pores near the center of the particles is greater than the predominant size of...
|
|
|
7588777 |
Surface cross-linked superabsorbent polymer particles and methods of making them
The present invention relates to superabsorbent polymer particles with improved surface cross-linking and their use in absorbent articles. The superabsorbent polymer particles of the present...
|
|
|
7585520 |
Compositions containing both sedative and non-sedative antihistamines and sleep aids
Compositions containing both a sedative compound and a non-sedative antihistamine are provided. More particularly, compositions for administration at bedtime containing a sedating antihistamine or...
|
|
|
7585493 |
Thin-film drug delivery article and method of use
An article for use in an aerosol device, for producing an aerosol of a drug composition is disclosed. The article includes a heat-conductive substrate having a surface with a selected surface area,...
|
|
|
7585521 |
Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
Controlled release ceramic particles, processes for their preparation, controlled release ceramic particles prepared by such processes, compositions comprising such controlled release ceramic...
|
|
|
7582284 |
Particulate materials
The present invention relates to active substances in particulate form, to methods for preparing them, to formulations containing them and to uses of such substances and formulations. A preferred...
|